DNA methylation of oxidative stress genes and cancer risk in the Normative Aging Study

American Journal of Cancer Research

Volumn 6, Issue 2, 2016, Pages 553-561

  Gao, Tao ^a   Joyce, Brian Thomas ^a,b   Liu, Lei ^a   Zheng, Yinan ^a   Dai, Qi ^c   Zhang, Zhou ^a   Zhang, Wei ^a   Shrubsole, Martha J ^c   Tao, Meng Hua ^d   Schwartz, Joel ^e   Baccarelli, Andrea ^e   Hou, Lifang ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cancer incidence; DNA methylation; Oxidative stress

Indexed keywords

8 OXOGUANINE DNA GLYCOSYLASE 1; CARNITINE ACETYLTRANSFERASE; DNA; DNA GLYCOSYLTRANSFERASE; GLUCOCORTICOID RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; CRAT GENE; DNA METHYLATION; EARLY DIAGNOSIS; FOLLOW UP; GCR GENE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INOS GENE; LEUKOCYTE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OGG1 GENE; OXIDATIVE STRESS; PROMOTER REGION; PROSPECTIVE STUDY; PROSTATE CANCER; PYROSEQUENCING; RISK ASSESSMENT;

EID: 84981762914     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Reuter S, Gupta SC, Chaturvedi MM and Aggarwal BB. Oxidative stress, inflammation, and cancer How are they linked? Free Radic Biol Med 2010; 49: 1603-1616.
2. Khandrika L, Kumar B, Koul S, Maroni P and Koul HK. Oxidative stress in prostate cancer. Cancer Lett 2009; 282: 125-136.
3. Visconti R and Grieco D. New insights on oxidative stress in cancer. Curr Opin Drug Discov Devel 2009; 12: 240-245.
4. Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358: 1148-1159.
5. Zhu ZZ, Sparrow D, Hou L, Tarantini L, Bollati V, Litonjua AA, Zanobetti A, Vokonas P, Wright RO, Baccarelli A and Schwartz J. Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the Normative Aging Study. Cancer Causes Control 2011; 22: 437-447.
6. Murata M, Thanan R, Ma N and Kawanishi S. Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis. J Biomed Biotechnol 2012; 2012: 623019.
7. Duthie SJ, Grant G, Pirie LP, Watson AJ and Margison GP. Folate deficiency alters hepatic and colon MGMT and OGG-1 DNA repair protein expression in rats but has no effect on genome-wide DNA methylation. Cancer Prev Res (Phila) 2010; 3: 92-100.
8. Hori Y, Oda Y, Kiyoshima K, Yamada Y, Nakashima Y, Naito S and Tsuneyoshi M. Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis. J Pathol 2007; 212: 218-226.
9. Bell B, Rose CL and Damon A. Normative Aging Study-Interdisciplinary and Longitudinal Study of Health and Aging. Aging and Human Development 1972; 3: 5-17.
10. Baccarelli A, Wright RO, Bollati V, Tarantini L, Litonjua AA, Suh HH, Zanobetti A, Sparrow D, Vokonas PS and Schwartz J. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med 2009; 179: 572-578.
11. Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, Suh H, Sparrow D, Vokonas P and Baccarelli A. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev 2009; 130: 234-239.
12. Bind MA, Baccarelli A, Zanobetti A, Tarantini L, Suh H, Vokonas P and Schwartz J. Air Pollution and Markers of Coagulation, Inflammation, and Endothelial Function Associations and Epigene-environment Interactions in an Elderly Cohort. Epidemiology 2012; 23: 332-340.
13. Bind MA, Lepeule J, Zanobetti A, Gasparrini A, Baccarelli A, Coull BA, Tarantini L, Vokonas PS, Koutrakis P and Schwartz J. Air pollution and gene-specific methylation in the Normative Aging Study. Epigenetics 2014; 9: 448-458.
14. Alexeeff SE, Baccarelli AA, Halonen J, Coull BA, Wright RO, Tarantini L, Bollati V, Sparrow D, Vokonas P and Schwartz J. Association between blood pressure and DNA methylation of retrotransposons and pro-inflammatory genes. Int J Epidemiol 2013; 42: 270-280.
15. Paz-Elizur T, Krupsky M, Blumenstein S, Elinger D, Schechtman E and Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 2003; 95: 1312-1319.
16. Asami S, Hirano T, Yamaguchi R, Tomioka Y, Itoh H and Kasai H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res 1996; 56: 2546-2549.
17. Cooke MS, Evans MD, Dizdaroglu M and Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003; 17: 1195-1214.
18. Wallace SS. Biological consequences of free radical-damaged DNA bases. Free Radic Biol Med 2002; 33: 1-14.
19. Paz-Elizur T, Ben-Yosef R, Elinger D, Vexler A, Krupsky M, Berrebi A, Shani A, Schechtman E, Freedman L and Livneh Z. Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer. Cancer Res 2006; 66: 11683-11689.
20. Audebert M, Chevillard S, Levalois C, Gyapay G, Vieillefond A, Klijanienko J, Vielh P, El Naggar AK, Oudard S, Boiteux S and Radicella JP. Alterations of the DNA repair gene OGG1 in human clear cell carcinomas of the kidney. Cancer Res 2000; 60: 4740-4744.
21. Gueranger Q, Li F, Peacock M, Larnicol-Fery A, Brem R, Macpherson P, Egly JM and Karran P. Protein oxidation and DNA repair inhibition by 6-thioguanine and UVA radiation. J Invest Dermatol 2014; 134: 1408-1417.
22. Zou B, Chim CS, Zeng H, Leung SY, Yang Y, Tu SP, Lin MC, Wang J, He H, Jiang SH, Sun YW, Yu LF, Yuen ST, Kung HF and Wong BC. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Gastroenterology 2006; 131: 1835-1843.
23. Paz-Elizur T, Elinger D, Leitner-Dagan Y, Blumenstein S, Krupsky M, Berrebi A, Schechtman E and Livneh Z. Development of an enzymatic DNA repair assay for molecular epidemiology studies: distribution of OGG activity in healthy individuals. DNA Repair (Amst) 2007; 6: 45-60.
24. Mazzei F, Guarrera S, Allione A, Simonelli V, Narciso L, Barone F, Minoprio A, Ricceri F, Funaro A, D'Errico M, Vogel U, Matullo G and Dogliotti E. 8-Oxoguanine DNA-glycosylase repair activity and expression: a comparison between cryopreserved isolated lymphocytes and EBV-derived lymphoblastoid cell lines. Mutat Res 2011; 718: 62-67.
25. Kosova F, Temeltas G, Ari Z and Lekili M. Possible relations between oxidative damage and apoptosis in benign prostate hyperplasia and prostate cancer patients. Tumour Biol 2014; 35: 4295-4299.
26. Muoio DM, Noland RC, Kovalik JP, Seiler SE, Davies MN, DeBalsi KL, Ilkayeva OR, Stevens RD, Kheterpal I, Zhang J, Covington JD, Bajpeyi S, Ravussin E, Kraus W, Koves TR and Mynatt RL. Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab 2012; 15: 764-777.
27. Seiler SE, Martin OJ, Noland RC, Slentz DH, De-Balsi KL, Ilkayeva OR, An J, Newgard CB, Koves TR and Muoio DM. Obesity and lipid stress inhibit carnitine acetyltransferase activity. J Lipid Res 2014; 55: 635-644.
28. Madrigano J, Baccarelli A, Mittleman MA, Sparrow D, Vokonas PS, Tarantini L and Schwartz J. Aging and epigenetics: longitudinal changes in gene-specific DNA methylation. Epigenetics 2012; 7: 63-70.
29. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS and Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A 1992; 89: 3030-3034.
30. Cronauer MV, Ince Y, Engers R, Rinnab L, Weidemann W, Suschek CV, Burchardt M, Kleinert H, Wiedenmann J, Sies H, Ackermann R and Kroncke KD. Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression. Oncogene 2007; 26: 1875-1884.
31. Nathan C and Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-13728.
32. Davis KL, Martin E, Turko IV and Murad F. Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 2001; 41: 203-236.
33. Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, Pairolero P, Trastek V, Jett J, Caporaso NE, Liotta LA and Harris CC. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res 2000; 6: 4739-4744.
34. Aaltoma SH, Lipponen PK and Kosma VM. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Anticancer Res 2001; 21: 3101-3106.
35. Aaltomaa SH, Lipponen PK, Viitanen J, Kankkunen JP, Ala-Opas MY and Kosma VM. The prognostic value of inducible nitric oxide synthase in local prostate cancer. BJU Int 2000; 86: 234-239.
36. Wang J, Torbenson M, Wang Q, Ro JY and Becich M. Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen. Urol Oncol 2003; 21: 117-122.
37. Kojima M, Morisaki T, Tsukahara Y, Uchiyama A, Matsunari Y, Mibu R and Tanaka M. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J Surg Oncol 1999; 70: 222-229.
38. Chan GC, Fish JE, Mawji IA, Leung DD, Rachlis AC and Marsden PA. Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J Immunol 2005; 175: 3846-3861.
39. Cianchi F, Cortesini C, Fantappie O, Messerini L, Schiavone N, Vannacci A, Nistri S, Sardi I, Baroni G, Marzocca C, Perna F, Mazzanti R, Bechi P and Masini E. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol 2003; 162: 793-801.
40. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC and Moncada S. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A 1995; 92: 4392-4396.
41. Folkman J, Watson K, Ingber D and Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58-61.
42. Felley-Bosco E. Role of nitric oxide in genotoxicity: implication for carcinogenesis. Cancer Metastasis Rev 1998; 17: 25-37.
43. Szarcvel Szic K, Declerck K, Vidakovic M and Vanden Berghe W. From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition? Clin Epigenetics 2015; 7: 33.
44. Janakiram NB and Rao CV. iNOS-selective inhibitors for cancer prevention: promise and progress. Future Med Chem 2012; 4: 2193-2204.
45. Shang ZJ, Li ZB and Li JR. In vitro effects of nitric oxide synthase inhibitor L-NAME on oral squamous cell carcinoma: a preliminary study. Int J Oral Maxillofac Surg 2006; 35: 539-543.
46. Singh S and Gupta AK. Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies. Cancer Chemother Pharmacol 2011; 67: 1211-1224.